| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $2.7B | $2.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | $1.2B | $1.1B | $1.7B | $1.3B | $1.4B | $0.9B |
| Net Income | $1.1B | $1.0B | $0.8B | $0.8B | $1.3B | $0.9B | $1.0B | $0.7B |
| EPS (Basic) | $2.95 | $2.73 | $2.20 | $2.06 | $3.56 | $2.45 | $2.61 | $1.78 |
| EPS (Diluted) | $2.94 | $2.72 | $2.20 | $2.05 | $3.54 | $2.45 | $2.60 | $1.77 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $20.7B | $20.8B | $20.0B | $20.2B | $21.2B | $20.3B | $21.2B | $20.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $9.3B | $9.2B | $8.5B | $8.5B | $9.5B | $9.2B | $10.2B | $9.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $11.0B | $11.0B | $11.1B | $11.2B | $11.0B | $10.5B | $10.3B | $10.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.6B | $1.6B | $1.5B | $1.5B | $1.3B | $1.3B | $1.5B | $1.4B |
| Investing Cash Flow | $-0.3B | $-1.2B | $-0.4B | $0.1B | $-0.4B | $0.7B | $-0.8B | $-0.4B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.3B | $-0.4B | $-1.1B | $-1.8B | $-0.6B | $-1.9B | $-0.7B | $-1.0B |